21 May 2013
Keywords: novo, raises, diabetes, commitment, nordisk, increased, its
Article | 15 April 1996
- Novo Nordisk has increased its commitment to Anergen's IDDM-AnergiX
drug for insulin-dependent diabetes, after encouraging data in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 April 1996
22 April 1996
8 April 1996
20 May 2013
© 2013 thepharmaletter.com